Orion tightens its belt with 205 job cuts
Finnish drugmaker Orion is to follow through on plans to cut its R&D workforce and shed 205 employees to sure up operations as generic pressure mounts on its leading Parkinson’s disease drugs.
Archives for January 8, 2009
Wyeth launches $1.35bn bid for Crucell
Wyeth is in discussions to acquire vaccine manufacturer Crucell, in a deal that media reports suggest could be valued at more than $1.35bn.
Akron selects Austin to expand client base
Drug raw materials maker Akron Biotechnology has selected Austin Chemical Company to help expand its client-base in the global biotech, pharmaceutical, and diagnostic industries.
FDA enters Costa Rica on global safety mission
The FDA has established its first permanent presence in Latin America by opening an office in Costa Rica as part of “Beyond Our Borders Initiative”, which has also seen the agency set up three sites in China.
Abbott PRINT’s map to siRNA delivery
Abbott Laboratories has licensed Liquidia Technologies’ PRINT nanoparticle technology for the delivery of siRNA-based therapeutics, which have the potential to improve the company’s cancer portfolio.
India a ‘hot’ destination for clinical trials
The proportion of global clinical trials conducted In India is expected to more than double between 2007 and 2012, according to market research firm RNCOS.
Should the FDA stare at transgenic goats?
Positive noises from an FDA panel on GTC Biotherapeutics’ recombinant antithrombin ATryn may further the use of transgenic animals for drug production but should the manufacturing process rather than the drug’s safety be our prime concern?
Bio-Imaging Tech sells CapMed to focus on clinical
Contract research organisation Bio-Imaging Technologies has decided to sell off its CapMed subsidiary in order to focus its efforts on its core business, providing imaging series to clinical investigators.